Learned Intermediary Doctrine
The learned intermediary doctrine holds that a pharmaceutical or medical device manufacturer satisfies its duty to warn end users of a product's risks by providing an adequate warning to the prescribing physician, rather than directly to the patient, on the theory that the physician evaluates the product's risks and benefits for the specific patient and translates that information into an individualized treatment decision. The doctrine is recognized in some form in nearly every U.S. jurisdiction for prescription products, and it functions as a central causation-adjacent defense in pharmaceutical and medical device mass torts: even where a plaintiff can show the manufacturer's warning was inadequate, the claim fails unless the plaintiff can also show that an adequate warning would have changed the prescribing physician's decision to prescribe or the patient's decision to take the product. A minority of jurisdictions recognize exceptions, most notably for direct-to-consumer advertised drugs, reasoning that the manufacturer's marketing bypasses the intermediary function the doctrine assumes. Defendants in pharmaceutical mass torts routinely depose prescribing physicians specifically to establish that the physician was independently aware of the risk at issue or would have prescribed the product regardless of any additional warning, directly attacking the causal link the doctrine requires plaintiffs to prove.
Learned intermediary causation is frequently the deciding factor at the individual claim level in pharmaceutical mass torts, since it operates independently of whether general causation and product defect are established docket-wide.
Funders evaluating claim-level risk in a pharmaceutical docket should weight cases by the strength of available prescriber testimony — a prescribing physician who testifies they would have changed the prescription with adequate warning materially strengthens a claim's specific causation profile, while an unavailable or adverse prescriber is a claim-level red flag independent of the docket's overall merits.
The procedural and settlement-administration machinery of multi-district litigation — case management orders, causation gatekeeping, settlement trusts, and the mechanics that determine when and how a mass tort docket resolves.
Mass Tort Finance →